Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Lilly's Dave Ricks Named Chief Executive Magazine's 2025 CEO of the Year


News provided by

Chief Executive Group

Apr 07, 2025, 07:00 ET

Share this article

Share toX

Share this article

Share toX

Dave Ricks, CEO of Eli Lilly and Company, has been named Chief Executive Magazine's 2025 Chief Executive of the Year by his peer CEOs.
Dave Ricks, CEO of Eli Lilly and Company, has been named Chief Executive Magazine's 2025 Chief Executive of the Year by his peer CEOs.

Chief Executive magazine today announced Dave Ricks, CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year by his peer CEOs. Ricks was selected by an independent committee of CEOs for his work leading the transformation of Lilly into one of the world's most vital and valuable pharmaceutical companies.

BRENTWOOD, Tenn., April 7, 2025 /PRNewswire-PRWeb/ -- Chief Executive magazine today announced Dave Ricks, CEO of Eli Lilly and Company, has been named 2025 Chief Executive of the Year by his peer CEOs. Ricks was selected by an independent committee of CEOs for his work leading the transformation of Lilly into one of the world's most vital and valuable pharmaceutical companies.

"Dave Ricks is an exemplary leader," said Ken Frazier, the former CEO of Merck and Chief Executive's 2021 CEO of the Year, who served on this year's selection committee. "His vision, resilience and commitment to Lilly's core values: scientific excellence, patient-centered care, ethical business practices and respect for people have led the company to unprecedented levels of success, as measured by societal and shareholder value."

"Dave Ricks is an exemplary leader," said Ken Frazier, the former CEO of Merck and Chief Executive's 2021 CEO of the Year. "His vision, resilience and commitment to Lilly's core values have led the company to unprecedented levels of success, as measured by societal and shareholder value."

Post this

Ricks, who began his career at Lilly in 1996 as a business development associate, became CEO in January 2017. In the eight years since he took over, Lilly has solidified its position as the most valuable publicly traded pharmaceutical company, with a market capitalization exceeding $780 billion as of early 2025.

Under Ricks, Lilly has positioned itself as the leader in glucagon-like peptide-1 (GLP-1)-based medicines to treat obesity and diabetes. The company's donanemab, a treatment for Alzheimer's, has been shown to slow disease progression. Ricks also reduced the price of its most-commonly prescribed insulins—Humalog and Humulin—by 70 percent, an industry-leading move that was lauded by patients, the U.S. Department of Health and Human Services and the American Diabetes Association.

"I am truly grateful to accept this award as recognition of the incredible work being undertaken by my Lilly colleagues around the world," said Ricks. "Their unwavering commitment to tackling the most critical health challenges with science, courage and persistence has yielded life-changing medicines for millions of people. It's a privilege to continue advancing our company's 150-year legacy, fully aware that our potential to transform human health has never been greater."

Said Stanley Bergman, CEO of Henry Schein and our 2017 CEO of the Year: "This is a well-deserved recognition for a leader who has not only delivered exceptional growth at Lilly but has done so with a rare combination of strategic clarity and deep respect for people. Under Dave's leadership, Lilly has accelerated innovation, scaled breakthrough treatments and created extraordinary shareholder value—all while fostering a culture grounded in purpose and integrity." Bergman also served on this year's selection committee.

Said Ted Bililies, Ph.D., global leader of transformative leadership and managing partner at AlixPartners, who serves as advisor to the CEO of the Year selection committee: "It is hard to think of a more transformative leader than Dave Ricks. He has set a clear and compelling vision at Lilly and never wavers from his goals, whether in the acceleration of drug development for the benefits of patients or in the service of his employees and community. Dave combines wise stewardship with compassion, focus and accountability."

Ricks' selection as 2025 CEO of the Year is scheduled to be celebrated at an invitation-only event hosted by Chief Executive Group this October.

About Chief Executive of the Year

Since 1986, Chief Executive of the Year honorees have been a who's who of American business leadership, including Lisa Su, Ed Bastian, Marc Benioff, Ken Frazier, Bill Gates, Brian Moynihan, Arne Sorenson, Michael Dell, A. G. Lafley, Marillyn Hewson, John Chambers, Fred Smith, Bob Iger, Anne Mulcahy, Larry Bossidy, Andy Grove and Herb Kelleher and many more. The honor recognizes courageous, long-term executive leadership in the service of shareholders and society. Learn more: ChiefExecutive.net/CEO-of-the-Year/

About the 2025 Selection Committee

The Chief Executive of the Year was selected by a committee of distinguished peer CEOs. The 2025 committee consists of Lisa Su (CEO, AMD and 2024 CEO of the Year); Ed Bastian, (CEO, Delta Air Lines and 2023 CEO of the Year); Marc Benioff (co-founder and CEO, Salesforce; 2022 CEO of the Year); Ken Frazier (former CEO, Merck; 2021 CEO of the Year); Brian Moynihan (CEO, Bank of America; 2020 CEO of the Year), Marillyn Hewson (former CEO, Lockheed Martin; 2018 CEO of the Year); Stanley Bergman (CEO of Henry Schein and our 2017 CEO of the Year); Adam Aron (president and CEO, AMC Entertainment), Carmine Di Sibio (former CEO, EY Global); Jason Girzadas, (CEO, Deloitte US); Dan Glaser (former CEO, Marsh McLennan), Fred Hassan (former chair, Bausch & Lomb; partner, Warburg Pincus); Tamara Lundgren (CEO, Radius Recycling); Robert Nardelli (CEO, XLR-8); Tom Quinlan III (CEO, RR Donnelley); and Jeffrey Sonnenfeld (president and CEO, The Yale Chief Executive Leadership Institute). Ted Bililies, Ph.D., global leader of transformative leadership and managing partner, AlixPartners, is the exclusive adviser to the 2025 Selection Committee.

About Chief Executive/Chief Executive Group

Since 1977 Chief Executive Group has been a leading community for business leaders, existing to improve the performance of C-suite leaders and corporate directors. We run some of the nation's most essential peer-networking communities, including the CFO Leadership Council, Chief and Senior Executive Networks and the Corporate Board Member Network and publish Chief Executive magazine, ChiefExecutive.net, Corporate Board Member magazine, BoardMember.com, CFOLeadership.com, and StrategicCHRO360.com. Learn more at ChiefExecutiveGroup.com.

Media Contact

Dan Bigman, Chief Executive Group, 1 2038894980, [email protected], chiefexecutive.net

SOURCE Chief Executive Group

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.